Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is the most common type and often carries a poor ...

Tongue cancer (TC) cells can enter a chemo-resistant state by activating pathways related to autophagy and cholesterol ...

Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is ...

Topping up your coffee cup throughout the day could provide some protection against common cancers affecting the mouth, ...

Dalnicastobart is under clinical development by Lyvgen Biopharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success ...

Researchers in Pune, from Rasayani Biologics, have discovered that Bioplatin, a nano-platinum-based oral compound, may ...

The main goal is to remove tumors, tissue ... you may get a dry mouth. With any cancer treatment, it might take a while before you know how it affects your disease. Stay in touch with your ...

Paclitaxel is under clinical development by InnoUp Farma and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR ...

Poster presentation details are below: Author: Molina et al Title: CID-078, a first-in-class oral cyclin A/B-RxL inhibitor, elicits anti-tumor activity in breast cancer patient-derived xenograft ...